Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: A better investment

Derpatriot

posted on Mar 15, 2008 08:31AM

if you divide the estimated $41,630,000 per year by the outstanding

shares of 391,000,000, you get an eps of .106. Multiply the eps

by the P/E of 15 and you get: $1.59 per share.

Hope that helps.

Banosser is giving us a very conserative estimate to work with.

I'm sure he hopes that the numbers will be much higher, IMO.

Best of luck

Deb

Share
New Message
Please login to post a reply